Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab

NCT00887965 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT00887965
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00887965 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab
Lead sponsor
Amgen
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2009
Completion date
August 31, 2010
Enrollment
15 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

low bone mass, low bone mineral density, osteoporosis, postmenopausal osteoporosis